Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-threo-3,4-dihydroxyphenylserine

EU orphan designation number: EU/3/07/465   
Active ingredient: L-threo-3,4-dihydroxyphenylserine
Indication: Treatment of orthostatic hypotension in patients with pure autonomic failure
Sponsor: H. Lundbeck A/S
Ottiliavej 9, DK-2500 Valby, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Orphan designation EMEA/OD/026/07 (2007)3819 of 02/08/2007
11/12/2007 Change of name and/or address of sponsor
01/04/2009 Transfer of orphan designation EMEA/OD/026/07/T/01 (2009)2487 of 27/03/2009
09/11/2010 Change of name and/or address of sponsor EMA/581017/2010
11/03/2011 Transfer of orphan designation EMEA/OD/026/07/T/02 (2011)1683 of 09/03/2011
08/12/2015 Transfer of orphan designation EMA/OD/026/07/T/03 (2015)8953 of 04/12/2015